Co-Authors
This is a "connection" page, showing publications co-authored by Albert Ko and Santos Bermejo.
Connection Strength
0.627
-
Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2. N Engl J Med. 2020 09 24; 383(13):1283-1286.
Score: 0.225
-
Maternal respiratory SARS-CoV-2 infection in pregnancy is associated with a robust inflammatory response at the maternal-fetal interface. Med (N Y). 2021 May 14; 2(5):591-610.e10.
Score: 0.059
-
Stability of SARS-CoV-2 RNA in Nonsupplemented Saliva. Emerg Infect Dis. 2021 04; 27(4):1146-1150.
Score: 0.059
-
Increased SARS-CoV-2 Testing Capacity with Pooled Saliva Samples. Emerg Infect Dis. 2021 04; 27(4).
Score: 0.059
-
SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity. Med (N Y). 2021 Mar 12; 2(3):263-280.e6.
Score: 0.058
-
Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators. J Immunol. 2021 01 15; 206(2):329-334.
Score: 0.057
-
Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT-qPCR primer-probe sets. Nat Microbiol. 2020 10; 5(10):1299-1305.
Score: 0.056
-
Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19. BMC Neurol. 2020 Jun 18; 20(1):248.
Score: 0.055